Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorUniversite de Picardie Jules Verne
About this trial
The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.
Eligibility criteria
Qualifiers
Aged 18-35 years
Healthy participant with no self-reported diagnosed neurological, musculoskeletal, or cardiovascular disorders
Body Mass Index (BMI) < 30
Ability to walk unaided for at least 10 minutes without major physical limitations
Disqualifiers
Presence of pain at the time of testing
Self-reported diagnosed condition affecting mobility
Known allergy to any component of the study cream
Allergy to EMG electrode adhesives
Trial design
Treatments tested in this trial
- Pain expectation conditioning
- Comparator (Control Group)
- Intervention: Gait
Treatment groups
34 Participants
are divided into 2 treatment groupsLocations
1Université de Picardie Jules Verne Amiens France
Sponsors and collaborators
Universite de Picardie Jules Verne
Lead sponsor
Source ClinicalTrials.gov